Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6,959 | 23,567 | 18,844 | 26,859 | 35,513 | 32,910 | 38,693 | 36,901 |
| EBITDA | 3,847 | 1,405 | 9,444 | 7,907 | 11,841 | 8,055 | 14,444 | 11,558 |
| Net profit | 4,269 | 1,298 | 7,848 | 4,291 | 9,422 | 9,121 | 13,299 | 12,934 |
| Total assets | 38,803 | 41,069 | 31,815 | 48,713 | 53,141 | 63,901 | 70,894 | 71,433 |
| n (companies reporting) | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 4 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| DSMTS - Damokidebulebis… | 0 | 3,719 | 4,275 | 5,683 | 8,201 | 10,410 | 8,139 | 9,838 |
| Laboratoria Mrcheveli | 0 | 2,800 | 3,759 | 4,661 | 5,751 | 6,191 | 7,374 | 9,826 |
| Akhali Mzera | 6,959 | 7,159 | 7,562 | 5,982 | 8,245 | 8,552 | 8,386 | 9,044 |
| Zurab Sabakhtarashvilis… | 0 | 2,670 | 3,248 | 4,124 | 5,838 | — | 7,026 | 8,194 |
| Radiation Medicine Cent… | 0 | 7,219 | 0 | 6,408 | 7,477 | 7,757 | 7,769 | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2017, FY2019, FY2021–FY2022, FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.